1
2
3
4
5
6
7 LONG TITLE
8 General Description:
9 This bill creates a pilot program.
10 Highlighted Provisions:
11 This bill:
12 ▸ defines terms; and
13 ▸ authorizes a healthcare system to create a pilot program for certain drugs.
14 Money Appropriated in this Bill:
15 None
16 Other Special Clauses:
17 None
18 Utah Code Sections Affected:
19 AMENDS:
20 63I-1-258, as last amended by Laws of Utah 2023, Chapter 303
21 ENACTS:
22 58-37-3.5, Utah Code Annotated 1953
23
24 Be it enacted by the Legislature of the state of Utah:
25 Section 1. Section 58-37-3.5 is enacted to read:
26 58-37-3.5. Drugs for behavioral health treatment.
27 (1) As used in this section:
28 (a) "Drug" means any form of psilocybin or methylenedioxymethamphetamine that is
29 in federal Food and Drug Administration Phase 3 testing for an investigational drug described
30 in 21 C.F.R. Part 312.
31 (b) "Healthcare system" means:
32 (i) a privately-owned, non-profit, vertically-integrated healthcare system that operates
33 at least 15 licensed hospitals in the state; or
34 (ii) a health care system closely affiliated with an institution of higher education
35 described in Section 53B-2-101.
36 (2) A healthcare system may develop a behavioral health treatment program that
37 includes a treatment based on a drug that the health system determines is supported by a broad
38 collection of scientific and medical research.
39 (3) A healthcare system described in Subsection (2):
40 (a) shall ensure that a drug used under the exclusive authority of this section is used by
41 a patient only under the direct supervision and control of the healthcare system and the
42 healthcare system's health care providers who are licensed under this title; and
43 (b) may not provide treatments that are authorized exclusively under this section to an
44 individual who is not at least 18 years old.
45 (4) Before July 1, 2026, a healthcare system that creates a behavioral health treatment
46 program under this section shall provide a written report to the Health and Human Services
47 Interim Committee regarding:
48 (a) drugs used;
49 (b) health outcomes of patients;
50 (c) side effects of any drugs used; and
51 (d) any other information necessary for the Legislature to evaluate the medicinal value
52 of any drugs.
53 (5) An individual or entity that complies with this section when using, distributing,
54 possessing, administering, or supervising the use of, a drug is not guilty of a violation of this
55 title.
56 Section 2. Section 63I-1-258 is amended to read:
57 63I-1-258. Repeal dates: Title 58.
58 (1) Section 58-3a-201, which creates the Architects Licensing Board, is repealed July
59 1, 2026.
60 (2) Title 58, Chapter 13, Health Care Providers Immunity from Liability Act, is
61 repealed July 1, 2026.
62 (3) Title 58, Chapter 15, Health Facility Administrator Act, is repealed July 1, 2025.
63 (4) Title 58, Chapter 20b, Environmental Health Scientist Act, is repealed July 1, 2028.
64 (5) Section 58-37-3.5 is repealed July 1, 2027.
65 [
66 restriction, is repealed July 1, 2032, and the Office of Legislative Research and General
67 Counsel is authorized to renumber the remaining subsections accordingly.
68 [
69 2033.
70 [
71 Act, is repealed July 1, 2029.
72 [
73 2025.
74 [
75 repealed July 1, 2033.
76 [
77 2024.
78 [
79 Licensing Advisory Board, is repealed July 1, 2027.
80 [
81 licensure and reporting, is repealed July 1, 2032.
82 [
83 July 1, 2026.
84 [
85 Section 3. Effective date.
86 This bill takes effect on May 1, 2024.